Goldenwell Biotech Stock Buy Hold or Sell Recommendation
| GWLL Stock | USD 2.01 0.28 12.23% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Goldenwell Biotech is 'Cautious Hold'. The recommendation algorithm takes into account all of Goldenwell Biotech's available fundamental, technical, and predictive indicators you will find on this site.
Check out Goldenwell Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Goldenwell and provide practical buy, sell, or hold advice based on investors' constraints. Goldenwell Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
Goldenwell |
Execute Goldenwell Biotech Buy or Sell Advice
The Goldenwell recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Goldenwell Biotech. Macroaxis does not own or have any residual interests in Goldenwell Biotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Goldenwell Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Moderate | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Goldenwell Biotech Trading Alerts and Improvement Suggestions
| Goldenwell Biotech is way too risky over 90 days horizon | |
| Goldenwell Biotech appears to be risky and price may revert if volatility continues | |
| Goldenwell Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 18.97 K. Net Loss for the year was (107.48 K) with profit before overhead, payroll, taxes, and interest of 8.39 K. | |
| Goldenwell Biotech currently holds about 42.86 K in cash with (202.57 K) of positive cash flow from operations. | |
| Roughly 63.0% of the company shares are held by company insiders |
Goldenwell Biotech Returns Distribution Density
The distribution of Goldenwell Biotech's historical returns is an attempt to chart the uncertainty of Goldenwell Biotech's future price movements. The chart of the probability distribution of Goldenwell Biotech daily returns describes the distribution of returns around its average expected value. We use Goldenwell Biotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Goldenwell Biotech returns is essential to provide solid investment advice for Goldenwell Biotech.
| Mean Return | 12.13 | Value At Risk | -12.23 | Potential Upside | 49.25 | Standard Deviation | 201.00 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Goldenwell Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Goldenwell Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Goldenwell Biotech or Consumer Defensive sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Goldenwell Biotech's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Goldenwell pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 10.38 | |
β | Beta against Dow Jones | 19.28 | |
σ | Overall volatility | 85.06 | |
Ir | Information ratio | 0.15 |
Goldenwell Biotech Volatility Alert
Goldenwell Biotech is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Goldenwell Biotech's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Goldenwell Biotech's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Goldenwell Biotech Fundamentals Vs Peers
Comparing Goldenwell Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Goldenwell Biotech's direct or indirect competition across all of the common fundamentals between Goldenwell Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Goldenwell Biotech or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Goldenwell Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Goldenwell Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Goldenwell Biotech to competition |
| Fundamentals | Goldenwell Biotech | Peer Average |
| Return On Equity | -36.4 | -0.31 |
| Return On Asset | -17.19 | -0.14 |
| Operating Margin | (568.00) % | (5.51) % |
| Current Valuation | 28.31 M | 16.62 B |
| Shares Outstanding | 96 M | 571.82 M |
| Shares Owned By Insiders | 62.50 % | 10.09 % |
| Price To Book | 98.33 X | 9.51 X |
| Revenue | 18.97 K | 9.43 B |
| Gross Profit | 8.39 K | 27.38 B |
| Net Income | (107.48 K) | 570.98 M |
| Cash And Equivalents | 42.86 K | 2.7 B |
| Total Debt | 32.87 K | 5.32 B |
| Debt To Equity | 0.14 % | 48.70 % |
| Current Ratio | 7.29 X | 2.16 X |
| Cash Flow From Operations | (202.57 K) | 971.22 M |
| Market Capitalization | 28.32 M | 19.03 B |
Goldenwell Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Goldenwell . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 2.01 | |||
| Day Typical Price | 2.01 | |||
| Price Action Indicator | (0.14) | |||
| Period Momentum Indicator | (0.28) |
About Goldenwell Biotech Buy or Sell Advice
When is the right time to buy or sell Goldenwell Biotech? Buying financial instruments such as Goldenwell Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Goldenwell Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Emerging Markets ETFs Thematic Idea Now
Emerging Markets ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Emerging Markets ETFs theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Emerging Markets ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Goldenwell Pink Sheet
Goldenwell Biotech financial ratios help investors to determine whether Goldenwell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goldenwell with respect to the benefits of owning Goldenwell Biotech security.